A possible way to improve the glycaemic control and the beta cell function during three years: the triple therapy

Trial Profile

A possible way to improve the glycaemic control and the beta cell function during three years: the triple therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 18 Feb 2013

At a glance

  • Drugs Glibenclamide (Primary) ; Sitagliptin (Primary) ; Metformin; Pioglitazone
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Oct 2012 New trial record
    • 05 Oct 2012 Results presented at the 48th Annual Meeting of the European Association for the Study of Diabetes.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top